Table 1.

Follow-up outcomes

	Total (N = 210), n (%)
Complications†
Cardiac	2 (1.0)
Pericardial	0 (0.0)
Vascular	4 (1.9)
Hemorrhage requiring transfusion	0 (0.0)
Pulmonary embolism	1 (0.5)
Postoperative stroke/TIA	3 (1.4)
Non-VT arrhythmias‡	87 (41.4)
ICD/CRT-D implantation‡	7 (3.3)
Beta-blocker use‡	89 (42.4)
AAD use‡	75 (35.7)
Class Ia	2 (1.0)
Class Ib	21 (10.0)
Class Ic	10 (4.8)
Class III	28 (13.3)
Class IV	40 (19.0)
Digoxin	1 (0.5)
Number of AADs‡
0	135 (64.3)
1	56 (26.7)
2	13 (6.2)
3	5 (2.4)
4	0 (0.0)
5	1 (0.5)

AAD = antiarrhythmic drug; AV = atrioventricular; ICD/CRT-D = implantable cardioverter-defibrillator/cardiac resynchronization therapy device; TIA = transient ischemic attack; VF = ventricular fibrillation; VT = ventricular tachycardia.

^†Index month

^‡Within 12 months.